On track to complete enrollment for the Phase 3 PROACT 1 accelerated approval analysis of rilparencel in mid-2026; anticipate ...

The number of Australians treated for kidney failure, including dialysis, over the past two decades has doubled to 2.7 ...

Vertex reported a phase 3 win for its kidney disease prospect povetacicept, meeting analyst expectations and firing the ...

The year 2025 marked a strong leap forward for Vietnamese medicine, as a series of complex techniques were successfully ...

Positive Phase 3 data from ORIGIN 3 study of atacicept in IgA nephropathy (IgAN) presented at American Society of Nephrology (ASN) Kidney Week ...

ICSE Class 10 Biology board exam is tomorrow! Boost your last-minute preparation with a list of the most repeated and important questions from previous years' papers.

Long-term lithium therapy remains the most effective maintenance treatment for bipolar disorder, yet it poses a significant ...

(9926.HK)  ("Akeso" or the "Company") announced today that its proprietary first-in-class trispecific antibody, AK150 (ILT2/ILT4/CSF1R), has received Investigational New Drug (IND) clearance from the ...

Survival in myeloma is clearly being prolonged,” says Mikhael. “Whereas historically, we saw a greater impact in younger ...

And just over a decade ago, it became one of the first established automakers to launch an electric car with the i3, a ...

The Dubbo community will benefit from an $8.2 million investment by the Minns Labor Government to deliver major upgrades to NSW Health Pathology’s laboratory at Dubbo Health Service.

New cars are expensive. This could be the official catch phrase for anyone looking to purchase a new vehicle in the year 2026 ...